Condition: Periprosthetic Joint Infections · Sponsor: Elute, Inc.
This is a pivotal, prospective, multi-center, randomized, concurrent control, patient and assessor-blinded study with two arms: a treatment arm (where subjects will be treated with the EP Granules + Tobramycin (EP G + T) investigational device, a combination device + antibiotic, in the 1st stage of a staged revision for periprosthetic joint infection (PJIs), and a control arm (where subjects are treated with the standard-of-care revision for infected PJIs).
This description comes directly from the study's public registry record.
Ashok Khandkar, PhD · 801-410-4330 · ak@elutinc.com
Eva Serio, BS · 801-410-4330 · eva@elutinc.com
Always discuss trial participation with your own doctor first.
| University of Southern California | Los Angeles, California, United States | Recruiting |
| Georgetown University Medical Center | Washington D.C., District of Columbia, United States | Recruiting |
| Endeavor Health Skokie Hospital | Skokie, Illinois, United States | Recruiting |
| OrthoIndy | Indianapolis, Indiana, United States | Recruiting |
| Sinai Hospital | Baltimore, Maryland, United States | Recruiting |
| Massachusetts General Hospital | Boston, Massachusetts, United States | Not Yet Recruiting |
| Brigham & Womens Hospital | Boston, Massachusetts, United States | Completed |
| U Michigan Medical Center | Ann Arbor, Michigan, United States | Recruiting |
| Hospital for Special Surgery | New York, New York, United States | Recruiting |
| OrthoCarolina | Charlotte, North Carolina, United States | Recruiting |
| Sanford South University Medical Center | Fargo, North Dakota, United States | Withdrawn |
| JIS Orthopedics | Columbus, Ohio, United States | Recruiting |
+ 4 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05361941